16.5 Million Patients Worldwide Are Remotely Monitored

16.5 Million Patients Worldwide Are Remotely Monitored

Foto: Depositphotos

The number of remotely monitored patients grew by 41 percent to 16.5 million in 2017 as the market acceptance continues to grow in several key verticals, according to research by Berg Insight.

This number includes all patients enrolled in mHealth care programs in which connected medical devices are used as a part of the care regimen. Connected medical devices used for various forms of personal health tracking are not included in this figure. Berg Insight estimates that the number of remotely monitored patients will grow at a compound annual growth rate (CAGR) of 31.0 percent to reach 83.4 million by 2023.

The two main applications are monitoring of patients with sleep therapy devices and monitoring of patients with implantable cardiac rhythm management devices. These two segments accounted for 82 percent of all connected home medical monitoring systems in 2017. The number of remotely monitored sleep therapy patients last year grew by 37 percent.

Telehealth is the third largest segment with 0.8 million connections at the end of the year. Other device categories, including ECG, glucose level, medication compliance, blood pressure monitors and others, accounted for just over two million connections. “The most promising segment is medication compliance, which we expect will become the second most connected segment in the next five years”, says Sebastian Hellström, IoT Analyst at Berg Insight.

More than 60 percent of all connected medical monitoring devices rely on cellular connectivity today and has become the de-facto standard for most types of connected home medical monitoring devices. The number of mHealth devices with integrated cellular connectivity increased from 7.1 million in 2016 to 10.7 million in 2017. The use of BYOD connectivity will increase the most during the next six years, with a forecasted CAGR of 48.2 percent.

“BYOD involves low cost and the technology is mostly adopted in patient-centric therapeutic areas such as diabetes and asthma that have younger patient demographics compared to many other chronic diseases. Many of these patients prefer to use their own smartphone as the interface instead of carrying around a dedicated device for remote monitoring”, concluded Hellström.

More from category

2019 Marketing Trends Report by IBM Watson Marketing

2019 Marketing Trends Report by IBM Watson Marketing

24 Jan 2019 comment

With AI continuing to gain usage among marketing professionals, IBM announced a new report from IBM Watson Marketing identifying a new breed of marketers coming to the forefront.

CEO Confidence in Growth Dips Dramatically

CEO Confidence in Growth Dips Dramatically

23 Jan 2019 comment

Nearly 30% of business leaders believe that global economic growth will decline in the next 12 months, approximately six times the level of 5% last year, a record jump in pessimism.

Six Technologies That Will Reach Mainstream Adoption in Five to Ten Years

Six Technologies That Will Reach Mainstream Adoption in Five to Ten Years

23 Jan 2019 comment

Of the 29 technologies on Gartner’s new Hype Cycle, eight are entering the Slope of Enlightenment and climbing toward the Plateau of Productivity.